The United States Human Insulin Market is on a trajectory of robust growth, with a projected Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period from 2022 to 2028, as reported by ...

Pharmaceutical firm, Eva Pharma, has introduced its range of diabetes medications to the Nigerian market, pledging to offer premium healthcare solutions at affordable prices. Eva Pharma announced ...

Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery ...

Glyxambi (empagliflozin/linagliptin) is a brand-name oral tablet prescribed to manage blood sugar in adults with type 2 diabetes. Glyxambi has interactions with some ...

But while the benefits of GLP-1 receptor agonists for the treatment of type 2 diabetes, obesity and cardiovascular disease are well known, their impact on chronic kidney disease (CKD) has been ...

Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study ...

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows. The two drugs are metformin, one of the most widely used ...

Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss? There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss.

The NHS is warning people to not take decongestants if they have a number of health issues such as diabetes or high blood ... their money on over-the-counter medications if they're suffering ...

Contraindications: This medication is not recommended for people with a history of heart disease, hypertension, hyperthyroidism, glaucoma, diabetes, pregnancy, and certain prescription medications.

The global advanced wound care market size was US$ 9.3 billion in 2021 and is forecast to reach $14.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast ...